HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Abstract
Of the most important clinical needs for bladder cancer (BC) management is the identification of biomarkers for disease aggressiveness. Urine is a "gold mine" for biomarker discovery, nevertheless, with multiple proteins being in low amounts, urine proteomics becomes challenging. In the present study we applied a fractionation strategy of urinary proteins based on the use of immobilized metal affinity chromatography for the discovery of biomarkers for aggressive BC. Urine samples from patients with non invasive (two pools) and invasive (two pools) BC were subjected to immobilized metal affinity chromatography fractionation and eluted proteins analyzed by 1D-SDS-PAGE, band excision and liquid chromatography tandem MS. Among the identified proteins, multiple corresponded to proteins with affinity for metals and/or reported to be phosphorylated and included proteins with demonstrated association with BC such as MMP9, fibrinogen forms, and clusterin. In agreement to the immobilized metal affinity chromatography results, aminopeptidase N, profilin 1, and myeloblastin were further found to be differentially expressed in urine from patients with invasive compared with non invasive BC and benign controls, by Western blot or Elisa analysis, nevertheless exhibiting high interindividual variability. By tissue microarray analysis, profilin 1 was found to have a marked decrease of expression in the epithelial cells of the invasive (T2+) versus high risk non invasive (T1G3) tumors with occasional expression in stroma; importantly, this pattern strongly correlated with poor prognosis and increased mortality. The functional relevance of profilin 1 was investigated in the T24 BC cells where blockage of the protein by the use of antibodies resulted in decreased cell motility with concomitant decrease in actin polymerization. Collectively, our study involves the application of a fractionation method of urinary proteins and as one main result of this analysis reveals the association of profilin 1 with BC paving the way for its further investigation in BC stratification.
AuthorsJerome Zoidakis, Manousos Makridakis, Panagiotis G Zerefos, Vasiliki Bitsika, Sergio Esteban, Maria Frantzi, Konstantinos Stravodimos, Nikolaos P Anagnou, Maria G Roubelakis, Marta Sanchez-Carbayo, Antonia Vlahou
JournalMolecular & cellular proteomics : MCP (Mol Cell Proteomics) Vol. 11 Issue 4 Pg. M111.009449 (Apr 2012) ISSN: 1535-9484 [Electronic] United States
PMID22159600 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • PFN1 protein, human
  • Profilins
  • CD13 Antigens
  • Myeloblastin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism, urine)
  • CD13 Antigens (urine)
  • Chromatography, Affinity
  • Chromatography, Liquid
  • Epithelial Cells (metabolism)
  • Humans
  • Middle Aged
  • Myeloblastin (urine)
  • Neoplasm Invasiveness
  • Neoplasm Proteins (metabolism, urine)
  • Profilins (metabolism, urine)
  • Stromal Cells (metabolism)
  • Tandem Mass Spectrometry
  • Urinary Bladder (metabolism, pathology)
  • Urinary Bladder Neoplasms (metabolism, pathology, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: